{"id":"https://openalex.org/W2148201382","doi":"https://doi.org/10.1158/1078-0432.ccr-13-2781","title":"Combinatorial Immunotherapy of Polyinosinic\u2013Polycytidylic Acid and Blockade of Programmed Death-Ligand 1 Induce Effective CD8 T-cell Responses against Established Tumors","display_name":"Combinatorial Immunotherapy of Polyinosinic\u2013Polycytidylic Acid and Blockade of Programmed Death-Ligand 1 Induce Effective CD8 T-cell Responses against Established Tumors","alternate_titles":[],"publication_year":2014,"publication_date":"2014-03-01","ids":{"openalex":"https://openalex.org/W2148201382","doi":"https://doi.org/10.1158/1078-0432.ccr-13-2781","mag":"2148201382","pmid":"https://pubmed.ncbi.nlm.nih.gov/24389326","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/3956448"},"language":"en","primary_location":{"id":"doi:10.1158/1078-0432.ccr-13-2781","doi":"https://doi.org/10.1158/1078-0432.ccr-13-2781","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1078-0432.ccr-13-2781","pdf_url":null,"source":{"id":"https://openalex.org/S183149254","display_name":"Clinical Cancer Research","issn_l":"1078-0432","issn":["1078-0432","1557-3265"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Cancer Research","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2148201382"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/3956448","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5026150840","display_name":"Toshihiro Nagato","orcid":"https://orcid.org/0000-0001-8326-8296","observed_orcids":["https://orcid.org/0000-0001-8326-8296"]},"institutions":[{"id":"https://openalex.org/I147809708","display_name":"Asahikawa Medical University","ror":"https://ror.org/025h9kw94","country_code":"JP","type":"education","lineage":["https://openalex.org/I147809708"]},{"id":"https://openalex.org/I2613432","display_name":"University of South Florida","ror":"https://ror.org/032db5x82","country_code":"US","type":"education","lineage":["https://openalex.org/I2613432"]},{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["JP","US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Toshihiro Nagato","raw_affiliation_strings":["Authors' Affiliations:\u20081Immunology Program, Moffitt Cancer Center; Departments of 2Oncologic Sciences and 3Molecular Medicine, University of South Florida, Tampa, Florida; and 4Department of Otolaryngology-Head and Neck Surgery, Asahikawa Medical University, Asahikawa, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations:\u20081Immunology Program, Moffitt Cancer Center; Departments of 2Oncologic Sciences and 3Molecular Medicine, University of South Florida, Tampa, Florida; and 4Department of Otolaryngology-Head and Neck Surgery, Asahikawa Medical University, Asahikawa, Japan","institution_ids":["https://openalex.org/I147809708","https://openalex.org/I2613432","https://openalex.org/I3019308854"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111336758","display_name":"Young-Ran Lee","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I147809708","display_name":"Asahikawa Medical University","ror":"https://ror.org/025h9kw94","country_code":"JP","type":"education","lineage":["https://openalex.org/I147809708"]},{"id":"https://openalex.org/I2613432","display_name":"University of South Florida","ror":"https://ror.org/032db5x82","country_code":"US","type":"education","lineage":["https://openalex.org/I2613432"]},{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["JP","US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Young-Ran Lee","raw_affiliation_strings":["Authors' Affiliations:\u20081Immunology Program, Moffitt Cancer Center; Departments of 2Oncologic Sciences and 3Molecular Medicine, University of South Florida, Tampa, Florida; and 4Department of Otolaryngology-Head and Neck Surgery, Asahikawa Medical University, Asahikawa, Japan","Departments of Oncologic Sciences and Molecular Medicine, University of South Florida, Tampa, Florida"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations:\u20081Immunology Program, Moffitt Cancer Center; Departments of 2Oncologic Sciences and 3Molecular Medicine, University of South Florida, Tampa, Florida; and 4Department of Otolaryngology-Head and Neck Surgery, Asahikawa Medical University, Asahikawa, Japan","institution_ids":["https://openalex.org/I147809708","https://openalex.org/I2613432","https://openalex.org/I3019308854"]},{"raw_affiliation_string":"Departments of Oncologic Sciences and Molecular Medicine, University of South Florida, Tampa, Florida","institution_ids":["https://openalex.org/I2613432"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015309592","display_name":"Yasuaki Harabuchi","orcid":"https://orcid.org/0000-0002-2870-1277","observed_orcids":["https://orcid.org/0000-0002-2870-1277"]},"institutions":[{"id":"https://openalex.org/I147809708","display_name":"Asahikawa Medical University","ror":"https://ror.org/025h9kw94","country_code":"JP","type":"education","lineage":["https://openalex.org/I147809708"]},{"id":"https://openalex.org/I2613432","display_name":"University of South Florida","ror":"https://ror.org/032db5x82","country_code":"US","type":"education","lineage":["https://openalex.org/I2613432"]},{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["JP","US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Yasuaki Harabuchi","raw_affiliation_strings":["Authors' Affiliations:\u20081Immunology Program, Moffitt Cancer Center; Departments of 2Oncologic Sciences and 3Molecular Medicine, University of South Florida, Tampa, Florida; and 4Department of Otolaryngology-Head and Neck Surgery, Asahikawa Medical University, Asahikawa, Japan","Departments of Oncologic Sciences and Molecular Medicine, University of South Florida, Tampa, Florida"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations:\u20081Immunology Program, Moffitt Cancer Center; Departments of 2Oncologic Sciences and 3Molecular Medicine, University of South Florida, Tampa, Florida; and 4Department of Otolaryngology-Head and Neck Surgery, Asahikawa Medical University, Asahikawa, Japan","institution_ids":["https://openalex.org/I147809708","https://openalex.org/I2613432","https://openalex.org/I3019308854"]},{"raw_affiliation_string":"Departments of Oncologic Sciences and Molecular Medicine, University of South Florida, Tampa, Florida","institution_ids":["https://openalex.org/I2613432"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5032554768","display_name":"Esteban Celis","orcid":"https://orcid.org/0000-0001-8299-4480","observed_orcids":["https://orcid.org/0000-0001-8299-4480"]},"institutions":[{"id":"https://openalex.org/I147809708","display_name":"Asahikawa Medical University","ror":"https://ror.org/025h9kw94","country_code":"JP","type":"education","lineage":["https://openalex.org/I147809708"]},{"id":"https://openalex.org/I2613432","display_name":"University of South Florida","ror":"https://ror.org/032db5x82","country_code":"US","type":"education","lineage":["https://openalex.org/I2613432"]},{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["JP","US"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Esteban Celis","raw_affiliation_strings":["Authors' Affiliations:\u20081Immunology Program, Moffitt Cancer Center; Departments of 2Oncologic Sciences and 3Molecular Medicine, University of South Florida, Tampa, Florida; and 4Department of Otolaryngology-Head and Neck Surgery, Asahikawa Medical University, Asahikawa, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations:\u20081Immunology Program, Moffitt Cancer Center; Departments of 2Oncologic Sciences and 3Molecular Medicine, University of South Florida, Tampa, Florida; and 4Department of Otolaryngology-Head and Neck Surgery, Asahikawa Medical University, Asahikawa, Japan","institution_ids":["https://openalex.org/I147809708","https://openalex.org/I2613432","https://openalex.org/I3019308854"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5032554768"],"corresponding_institution_ids":["https://openalex.org/I147809708","https://openalex.org/I2613432","https://openalex.org/I3019308854"],"apc_list":null,"apc_paid":null,"fwci":3.8805,"has_fulltext":false,"cited_by_count":108,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.94510116,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":94,"max":99},"biblio":{"volume":"20","issue":"5","first_page":"1223","last_page":"1234"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.6786999702453613,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.6786999702453613,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.3197999894618988,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10031","display_name":"T-cell and B-cell Immunology","score":0.0005000000237487257,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/polyinosinic-polycytidylic-acid","display_name":"polyinosinic-polycytidylic acid","score":0.9850000143051147},{"id":"https://openalex.org/keywords/pd-l1-blockade","display_name":"PD-L1 blockade","score":0.859000027179718},{"id":"https://openalex.org/keywords/anti-pd-l1-monoclonal-antibody","display_name":"anti-PD-L1 monoclonal antibody","score":0.953000009059906},{"id":"https://openalex.org/keywords/cd8-t-cell-responses","display_name":"CD8+ T cell responses","score":0.7940000295639038},{"id":"https://openalex.org/keywords/cancer-immunotherapy","display_name":"cancer immunotherapy","score":0.7260000109672546},{"id":"https://openalex.org/keywords/tumor-associated-antigens","display_name":"tumor-associated antigens","score":0.8270000219345093},{"id":"https://openalex.org/keywords/type-i-interferon","display_name":"type I interferon","score":0.8270000219345093},{"id":"https://openalex.org/keywords/melanoma","display_name":"melanoma","score":0.8389999866485596},{"id":"https://openalex.org/keywords/lung-cancer","display_name":"lung cancer","score":0.9710000157356262},{"id":"https://openalex.org/keywords/colon-cancer","display_name":"colon cancer","score":0.9900000095367432},{"id":"https://openalex.org/keywords/tumor-rechallenge","display_name":"tumor rechallenge","score":0.6679999828338623}],"concepts":[{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.7516382932662964},{"id":"https://openalex.org/C2778468042","wikidata":"https://www.wikidata.org/wiki/Q273976","display_name":"Blockade","level":3,"score":0.6623293161392212},{"id":"https://openalex.org/C167672396","wikidata":"https://www.wikidata.org/wiki/Q417800","display_name":"CD8","level":3,"score":0.6058728098869324},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5757918357849121},{"id":"https://openalex.org/C31573885","wikidata":"https://www.wikidata.org/wiki/Q304484","display_name":"Programmed cell death","level":3,"score":0.43553924560546875},{"id":"https://openalex.org/C116569031","wikidata":"https://www.wikidata.org/wiki/Q899107","display_name":"Ligand (biochemistry)","level":3,"score":0.41835343837738037},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3643271327018738},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.34819847345352173},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.3456313908100128},{"id":"https://openalex.org/C190283241","wikidata":"https://www.wikidata.org/wiki/Q14599311","display_name":"Apoptosis","level":2,"score":0.247224360704422},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.23417308926582336},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.18723508715629578},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.10699179768562317},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.09930363297462463}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D004195","descriptor_name":"Disease Models, Animal","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007167","descriptor_name":"Immunotherapy","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007370","descriptor_name":"Interferon Type I","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D007371","descriptor_name":"Interferon-gamma","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D008546","descriptor_name":"Melanoma, Experimental","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D011070","descriptor_name":"Poly I-C","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D016176","descriptor_name":"T-Lymphocyte Subsets","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D016176","descriptor_name":"T-Lymphocyte Subsets","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D018345","descriptor_name":"Mice, Knockout","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018414","descriptor_name":"CD8-Positive T-Lymphocytes","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D018414","descriptor_name":"CD8-Positive T-Lymphocytes","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D060890","descriptor_name":"B7-H1 Antigen","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D060890","descriptor_name":"B7-H1 Antigen","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true}],"locations_count":4,"locations":[{"id":"doi:10.1158/1078-0432.ccr-13-2781","doi":"https://doi.org/10.1158/1078-0432.ccr-13-2781","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1078-0432.ccr-13-2781","pdf_url":null,"source":{"id":"https://openalex.org/S183149254","display_name":"Clinical Cancer Research","issn_l":"1078-0432","issn":["1078-0432","1557-3265"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Cancer Research","raw_type":"journal-article"},{"id":"pmid:24389326","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/24389326","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical cancer research : an official journal of the American Association for Cancer Research","raw_type":"Journal Article"},{"id":"pmh:oai:europepmc.org:3308018","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/3956448","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":null,"raw_type":"Text"},{"id":"pmh:oai:pubmedcentral.nih.gov:3956448","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC3956448/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"Clin Cancer Res","raw_type":"Text"}],"best_oa_location":{"id":"pmh:oai:europepmc.org:3308018","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/3956448","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":null,"raw_type":"Text"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G5570162694","display_name":"Interferon-gamma limits the effectiveness of peptide vaccines for cancer","funder_award_id":"R01CA157303","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G7036409457","display_name":"Treatment of Melanoma with Optimzed Peptide Vaccines","funder_award_id":"R01CA136828","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"}],"funders":[{"id":"https://openalex.org/F4320306143","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03"},{"id":"https://openalex.org/F4320309468","display_name":"Memorial Sloan-Kettering Cancer Center","ror":"https://ror.org/02yrq0923"},{"id":"https://openalex.org/F4320311073","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524"},{"id":"https://openalex.org/F4320332161","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88"},{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":51,"referenced_works":["https://openalex.org/W1493822493","https://openalex.org/W1512834386","https://openalex.org/W1514805864","https://openalex.org/W1541097619","https://openalex.org/W1660417362","https://openalex.org/W1949743561","https://openalex.org/W1967608949","https://openalex.org/W1974176583","https://openalex.org/W1980704214","https://openalex.org/W1983255630","https://openalex.org/W1984545852","https://openalex.org/W1986222655","https://openalex.org/W1987419864","https://openalex.org/W1996642272","https://openalex.org/W2002250199","https://openalex.org/W2010709305","https://openalex.org/W2016671320","https://openalex.org/W2016789384","https://openalex.org/W2016983859","https://openalex.org/W2035686689","https://openalex.org/W2049345643","https://openalex.org/W2051316659","https://openalex.org/W2053353274","https://openalex.org/W2057499380","https://openalex.org/W2071670416","https://openalex.org/W2076042280","https://openalex.org/W2076361525","https://openalex.org/W2080816681","https://openalex.org/W2088801927","https://openalex.org/W2089892946","https://openalex.org/W2092976034","https://openalex.org/W2095881540","https://openalex.org/W2100143031","https://openalex.org/W2100262165","https://openalex.org/W2101277086","https://openalex.org/W2101653483","https://openalex.org/W2108855090","https://openalex.org/W2113664558","https://openalex.org/W2115741810","https://openalex.org/W2133499518","https://openalex.org/W2137405984","https://openalex.org/W2138869536","https://openalex.org/W2144182715","https://openalex.org/W2147346150","https://openalex.org/W2151246207","https://openalex.org/W2154478576","https://openalex.org/W2156067155","https://openalex.org/W2158153035","https://openalex.org/W2160834915","https://openalex.org/W2165948908","https://openalex.org/W2170904230"],"related_works":["https://openalex.org/W1595646630","https://openalex.org/W2066911216","https://openalex.org/W4309245121","https://openalex.org/W4380029942","https://openalex.org/W4317518409","https://openalex.org/W1964080141","https://openalex.org/W2077165389","https://openalex.org/W2587788427","https://openalex.org/W4393071365","https://openalex.org/W2339432535"],"abstract_inverted_index":{"PURPOSE:":[0],"Epitope-based":[1],"cancer":[2,86],"vaccines":[3],"capable":[4],"of":[5,27,30,46,56,104,113,133,168,182,192,213,216],"inducing":[6],"CD8":[7,153],"T-cell":[8],"responses":[9,124],"to":[10,95,200],"tumor-associated":[11],"antigens":[12],"(TAA)":[13],"expressed":[14],"by":[15,189],"tumor":[16,134,147],"cells":[17,155,160,163],"have":[18,35,80],"been":[19,37,81],"considered":[20],"as":[21,239],"attractive":[22],"alternatives":[23],"for":[24,39,74,225],"the":[25,44,53,101,105,127,139,165,179,190,214],"treatment":[26],"some":[28,137],"types":[29],"cancer.":[31],"However,":[32],"reliable":[33,235],"TAAs":[34,79,236],"not":[36,157,198],"identified":[38],"most":[40],"malignant":[41],"diseases,":[42],"limiting":[43],"development":[45],"epitope-based":[47],"vaccines.":[48],"Herein,":[49],"we":[50],"report":[51],"that":[52,152,178,210],"combinatorial":[54,170,184],"therapy":[55,142,185],"polyinosinic-polycytidylic":[57],"acid":[58],"(poly-IC)":[59],"and":[60,91,99,115],"antiprogrammed":[61],"death-ligand":[62],"1":[63],"(PD-L1)":[64],"monoclonal":[65],"antibody":[66],"(mAb)":[67],"can":[68],"be":[69,220],"implemented":[70],"with":[71,228],"good":[72],"results":[73,150,208],"tumors":[75],"where":[76,233],"no":[77,234],"known":[78],"identified.":[82],"EXPERIMENTAL":[83],"DESIGN:":[84],"Three":[85],"mouse":[87],"models":[88],"(melanoma,":[89],"lung,":[90],"colon)":[92],"were":[93],"used":[94],"evaluate":[96],"therapeutic":[97,166,180,241],"efficacy":[98,167,181],"examine":[100],"immunologic":[102],"mechanisms":[103],"poly-IC/anti-PD-L1":[106,140,217],"mAb":[107,117,141,218],"therapy.":[108,171],"RESULTS:":[109],"The":[110,149,206],"combined":[111],"administration":[112],"poly-IC":[114],"anti-PD-L1":[116],"into":[118],"tumor-bearing":[119],"mice":[120,176],"generated":[121],"potent":[122],"immune":[123],"resulting":[125],"in":[126,187],"complete":[128],"eradication":[129],"or":[130,161],"remarkable":[131],"reduction":[132],"growth.":[135],"In":[136],"instances,":[138],"induced":[143],"long-lasting":[144],"protection":[145],"against":[146],"rechallenges.":[148],"indicate":[151,177],"T":[154,159],"but":[156],"CD4":[158],"NK":[162],"mediated":[164],"this":[169,183],"Experiments":[172],"using":[173],"genetically":[174],"deficient":[175],"depended":[186],"part":[188],"participation":[191],"type-I":[193],"IFN,":[194],"whereas":[195],"IFN-\u03b3":[196],"did":[197],"seem":[199],"play":[201],"a":[202,221,240],"major":[203],"role.":[204],"CONCLUSIONS:":[205],"overall":[207],"suggest":[209],"immunotherapy":[211],"consisting":[212],"combination":[215],"could":[219],"promising":[222],"new":[223],"approach":[224],"treating":[226],"patients":[227],"cancer,":[229],"especially":[230],"those":[231],"instances":[232],"are":[237],"available":[238],"vaccine.":[242]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2148201382","counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":3},{"year":2024,"cited_by_count":6},{"year":2023,"cited_by_count":6},{"year":2022,"cited_by_count":16},{"year":2021,"cited_by_count":12},{"year":2020,"cited_by_count":11},{"year":2019,"cited_by_count":10},{"year":2018,"cited_by_count":10},{"year":2017,"cited_by_count":12},{"year":2016,"cited_by_count":10},{"year":2015,"cited_by_count":6},{"year":2014,"cited_by_count":4}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2016-06-24T00:00:00"}
